Effect of some pharmaceutical excipients on the survival of probiotic vaginal lactobacilli

Canadian Journal of Microbiology

Volumn 51, Issue 6, 2005, Pages 483-489

  Zárate, Gabriela ^a   Juárez Tomás, María Silvina ^a   Nader Macias, María Elena ^a  

^a CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

Author keywords

Pharmaceutical excipients; Probiotics; Vaginal lactobacilli; Viability

Indexed keywords

CELLS; DAIRY PRODUCTS; DRUG PRODUCTS; GLYCEROL; MICROBIOLOGY;

PHARMACEUTICAL EXCIPIENTS; PROBIOTICS; VAGINAL LACTOBACILLI; VIABILITY;

MICROORGANISMS;

EXCIPIENT; GELATIN; GLYCEROL; PROBIOTIC AGENT;

BACTERIUM;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIUM CULTURE; CONTROLLED STUDY; FEMALE; HUMAN; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS ACIDOPHILUS CRL 1259; LACTOBACILLUS SALIVARIUS; MILK; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TEMPERATURE DEPENDENCE; UROGENITAL SYSTEM; VAGINA; VAGINA FLORA;

ANIMALS; ASCORBIC ACID; EXCIPIENTS; FEMALE; HUMANS; LACTOBACILLUS; MILK; PROBIOTICS; SPECIES SPECIFICITY; VAGINA;

BACTERIA (MICROORGANISMS); LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CRISPATUS; LACTOBACILLUS SALIVARIUS;

EID: 27844460526     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/w05-031     Document Type: Article

References (40)

1. Block, L.H. 1985. Aplicaciones medicinales. In Farmacia. Edited by Remington. Editorial Médica Panamericana. pp. 2146-2151.
2. Boris, S., and Barbés, C. 2000. Role played by lactobacilli in controlling the population of vaginal pathogens. Microbes Infect. 2: 543-546.
3. Brashears, M.M., and Gilliland, S.E. 1995. Survival during frozen and subsequent refrigerated storage of Lactobacillus acidophilus cells as influenced by the growth phase. J. Dairy Sci. 78: 2326-2335.
4. Carvalho, A.S., Silva, J., Ho, P., Teixeira, P., Malcata, F.X., and Gibbs, P. 2002. Survival of freeze-dried Lactobacillus plantarum and Lactobacillus rhamnosus during storage in the presence of protectants. Biotechnol. Lett. 24: 1587-1591.
5. Carvalho, A.S., Silva, J., Ho, P., Teixeira, P., Malcata, F.X., and Gibbs, P. 2003. Effect of various growth media upon survival during storage of freeze-dried Enterococcus faecalis and Enterococcus durans. J. Appl. Microbiol. 94: 947-952.
6. Castro, H.P., Teixeira, P.M., and Kirby, R. 1996. Changes in the membrane of Lactobacillus bulgaricus during storage following freeze drying. Biotechnol. Lett. 18: 99-104.
7. Cauci, S., Driussi, S., De Santo, D., Penacchioni, P., Iannicelli, T., Lanzafame, P. et al. 2002. Prevalence of bacterial vaginosis and vaginal flora changes in peri- and postmenopausal women. J. Clin. Microbiol. 40: 2147-2152.
8. Chlebecek, J., and Reich, I. 1993. Fermalac Vaginal (Rougier Inc.) in the prevention of colpitis pregnancy. Cesk. Gynekol. 58: 237-238.
9. Combes, T., and Salhi, A. 1997. Données microbiologiques nouvelles sur la souche de Lactobacillus contenue dans la spécialité Tropigil. Rev. Fr. Gynécol. Obstet. 92: 183-187.
10. El-Kest, S.E., and Marth, E.H. 1991. Injury and death of frozen Listeria monocytogenes as affected by glycerol and milk components. J. Dairy Sci. 74: 1201-1208.
11. Gagné, J., Roy, D., and Gauthier, S.F. 1993. Production of frozen and freeze dried concentrates of Bifidobacterium infantis by membrane filtration. Milchwissenchaft, 48(9): 501-505.
12. Garg, S., Tambwekar, K.R., Vermani, K., Garg, A., Kaul, C.L., and Zaneveld, J.D. 2001. Compendium of pharmaceutical excipients for vaginal formulations. Pharm. Technol. Drug Deliv. 14-24. Available from www.phamatech.com.
13. Gómez Zavaglia, A., Disalvo, E.A., and De Antoni, G.L. 2000. Fatty acid composition and freeze-thaw resistance in lactobacilli. J. Dairy Res. 67: 241-247.
14. 2- producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections. J. Infect. Dis. 178: 446-450.
15. Hawes, S.E., Hillier, S.L., Benedetti, J., Stevens, C.E., Kousty, L.A., Wolner-Hanssen, P., and Holmes, K.K. 1996. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J. Infect. Dis. 174: 1058-1063.
16. Hughes, V.L., and Hillier, S. 1990. Microbiologic characteristics of Lactobacillus products used for colonization of the vagina. Obstet. Gynecol. 75: 244-248.
17. Juárez Tomás, M.S., Bru, E., Wiese, B., de Ruiz Holgado, A.P., and Nader-Macías, M.E. 2002. Influence of pH, temperature and culture media on the growth and bacteriocin production of vaginal Lactobacillus salivarius CRL 1328. J. Appl. Microbiol. 93: 714-724.
18. Juárez Tomás, M.S., Bru, E., and Nader-Macías, M.E. 2003a. Comparison of the growth and hydrogen peroxide production by vaginal probiotic lactobacilli under different culture conditions. Am. J. Obstet. Gynecol. 188: 35-44.
19. Juárez Tomás, M.S., Ocaña, V., Wiese, B., and Nader-Macías, M.E. 2003b. Growth and lactic acid production by vaginal Lactobacillus acidophilus CRL 1259. Inhibition of uropathogenic Escherichia coli. J. Med. Microbiol. 52: 1117-1124.
20. Juárez Tomás, M.S., Ocaña, V., and Nader-Macías, M.E. 2004. Viability of vaginal probiotic lactobacilli during refrigerated and frozen storage. Anaerobe, 10: 1-5.
21. Lepargneur, J.P., and Rousseau, V 2002. Protective role of the Doderlein flora. J. Gynecol. Obstet. Biol. Reprod. 31: 485-494.
22. Maggi, L., Mastromarino, P., Macchia, S., Brigidi, P., Pirovano, K, Mateuzzi, D., and Conte, U. 2000. Technological and biological evaluation of tablets containing different strains of lactobacilli for vaginal administration. Eur. J. Pharm. Biopharm. 50: 389-395.
23. Martin, H.L. Jr., Richardson, B.A., Nyange, P.M., Lavreys, L., Hillier, S.L., Chohan, B. et al. 1999. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J. Infect. Dis. 180: 1863-1868.
24. Mäyra-Mäkinen, A., and Bigret, M. 1998. Industrial use and production of lactic acid bacteria. In Lactic acid bacteria: microbiology and functional aspects. Edited by S. Salminen, and A. von Wright. Marcel Dekker, Inc., New York. pp. 73-102.
25. Nighswonger, B.D., Brashears, M.M., and Gilliland, S.E. 1996. Viability of Lactobacillus acidophilus and Lactobacillus casei in fermented milk products during refrigerated storage. J. Dairy Sci. 79: 212-219.
26. Ocaña, V., and Nader-Macías, M.E. 2001. Adhesion of Lactobacillus vaginal strains with probiotic properties to vaginal epithelial cells. Biocell, 25(3): 265-273.
27. Ocaña, V.S., and Nader-Macías, M.E. 2002. Vaginal lactobacilli: self and co-aggregating ability. Br. J. Biomed. Sci. 59(4): 183-190.
28. Ocaña, V.S., Bru, E., de Ruiz Holgado, A.P., and Nader-Macías, M.E. 1999a. Surface characteristics of lactobacilli isolated from human vagina. J. Gen. Appl. Microbiol. 45: 203-212.
29. 2-generating Lactobacillus for probiotic use. Curr. Microbiol. 38: 279-284.
30. Ocaña, V.S., de Ruiz Holgado, A.P., and Nader-Macías, M.E. 1999c. Characterization of a bacteriocin-like substance produced by a vaginal Lactobacillus salivarius strain. Appl. Env. Microbiol. 65: 5631-5635.
31. Raibaud, P., Galpin, J.V., Ducluzeau, R., Mocquot, G., and Oliver, G. 1973. Le genre Lactobacillus dans le tube digestif du rat. II Caracters de souches heterofermentaires isolées de rats "holo" et "gnotoxeniques". Annales de Microbiologie (Annales de L'Institut Pasteur), 124A: 2223-2235.
32. Redondo-López, V., Cook, R.L., and Sobel, J.D. 1990. Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Rev. Infect. Dis. 12(5): 856-872.
33. Reid, G., and Bruce, A.W. 2001. Selection of Lactobacillus strains for urogenital probiotic applications. J. Infect. Dis. 183(Suppl. 1): S77-S80.
34. Reid, G., and Burton, J. 2002. Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes Infect. 4: 319-324.
35. Reid, G., Bruce, A.W., and Taylor, M. 1995. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol. Ther. 23: 32-45.
36. Reid, G., Soboh, F., Bruce, A.W., and Mittelman, M. 1998. Effect of nutrient composition on the in vitro growth of urogenital lactobacilli and uropathogens. Can. J. Microbiol. 44: 866-871.
37. Reid, G., Beuerman, D., Heinemann, C., and Bruce, A.W. 2001. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol. Med. Microbiol. 32: 37-41.
38. Reid, G., Charbonneau, D., Erb, J., Kochanowski, B., Beuerman, D., Poehner, R., and Bruce, A.W. 2003. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol. Med. Microbiol. 35: 131-134.
39. Sewankambo, N., Gray, R.H., Wawer, M.J., Paxton, L., McNairn, D., Wabwire-Mangen, F., et al. 1997. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet, 350: 546-550.
40. Velraeds, M., van de Belt-Gritter, B., van der Mei, H., Reid, G., and Busscher, H. 1998. Interference in initial adhesion of uropathogenic bacteria and yeasts and silicone rubber by a Lactobacillus acidophilus biosurfactant. J. Med. Microbiol. 47: 1081-1085.